🇺🇸

US SEC Filing Intelligence

· daily

US SEC Filings Daily Market Digest — October 22, 2026

Across this 50-filing day, the dominant theme is divergence: strong top-line and earnings momentum at several large caps and regional banks (Element Solutions, CSX, IBM, Hexcel, Crown Castle's guidance raise, EastGroup, First Merchants, Eagle Bancorp) sits alongside credit and funding stress, going-concern-style listing pressure, and leverage strain at others (America's Car-Mart's fresh senior secured loans and covenant-driven amendments, Genenta's sub-$1 Nasdaq deficiency, Armour Residential's (12.9)% economic return and 8.24:1 leverage). Banks show a consistent pattern of sequentially improving margins and provisions alongside rising nonperforming assets and softer deposits (CNB Financial's deposits down $32.6M with NPAs at $56.9M, Beacon Financial's deposits down $303.3M and NPAs at $163.1M, Eagle's NPAs up $52.9M to $166.0M). Mortgage and housing-linked franchises are softening (First American flagged lower-for-longer origination; First Community's mortgage production fell 11.0% YoY), while commercial aerospace and industrial/infrastructure demand remain firm (Hexcel commercial aerospace +20.5%, CSX volume +5%). Capital return is active but selective: buybacks authorized at Beacon ($125M), Hexcel ($750M), EverQuote ($50M), and dividend increases at EastGroup (+12.9%) and First American (+11%). Watch items cluster around the November 4 earnings wave, the November 10 Alaunos Nasdaq panel hearing, and the November 25 Caesarstone AGM. Note that several filings (Acco Group, Alaunos) carry the largest financial-quality or listing-risk signals and deserve priority review despite their smaller or more technical footprints.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 22, 2026

Across the four filings, the Consumer Discretionary stream shows a split picture: top-line pressure at Las Vegas Sands (Q3 revenue down roughly 3% YoY to $3.22B, net income down about 28%) and Tesla's core automotive economics (Q3 revenue flat at -0.2%, operating income down 55.8%, net income attributable to common down 42.7%), offset by Tesla's nine-month revenue growth of 12.5% to $78.7B. Margin compression is the dominant theme: LVS consolidated adjusted property EBITDA fell from $1.34B to $1.12B, and Tesla's R&D spend rose 69.4% to $2.76B, crowding out operating income. Capital returns remain a strength for LVS, which repurchased $950M of stock in the quarter and lifted its 2027 dividend 20% to $1.44/share, while rising borrowing costs (4.7% vs 4.5%) and a higher effective tax rate (22.5% vs 15.6%) weigh on earnings. eBay's 8-K signals a restructuring with workforce reductions and expense savings, though the excerpt provides no quantified costs or headcount figures. Starbucks' filing is a routine, small 10b5-1 sale by its CEO-level insider and carries limited signal. Overall, the market implication is that profitability, not demand, is the central debate for these names, with restructuring and capital allocation decisions shaping the near-term narrative.

2 high priority 2 medium 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 22, 2026

This digest covers a single pre-analyzed filing in the USA S&P 500 Healthcare stream: a Form 4 for Vertex Pharmaceuticals, in which director Daniel J. Brennan received a routine equity award of 795 common shares at $503.47 (about $400K) and now holds 795 shares following the transaction. The filing carries neutral sentiment and a materiality score of 5/10. No period-over-period financial comparisons, forward-looking guidance, M&A details, or capital allocation changes were included in the enriched data, so portfolio-level trend analysis across companies is not possible from this filing alone. The only insider activity is a compensation-related grant, which signals neither conviction nor concern on its own. The primary takeaway is that no actionable investment signal emerges from this single filing; the stream would benefit from additional filings to establish sector-level patterns.

1 high priority 1 total filings
· daily

US Earnings Financial Results SEC Filings — October 22, 2026

Across 50 Q3/FY2026 SEC filings, revenue growth was broadly healthy but earnings quality diverged sharply: top-line expansion (Allegion +9.6%, Waste Connections +7.3%, Lam Research +54.4%, Comfort Systems +53.7%, Newmont sales +15.2%) frequently coexisted with weaker operating cash flow, rising interest costs, or one-time items that flattered net income (Honeywell's $6,629M deconsolidation gain, Visteon's tax-driven Q3 swing, Meta's tax-driven net income gain despite a 36.7% operating income decline). Margin compression was common among consumer, transport and financial names (American Airlines operating income -23.8%, Southwest fuel +61.7%, PulteGroup home-sale margin contraction, Synchrony efficiency ratio up to 35.9%), while semiconductor equipment and AI/infrastructure-linked names (Lam Research, Comfort Systems Technology segment +104%) showed the strongest momentum. Capital returns remained large but were increasingly debt-funded or concentrated: PulteGroup, Waste Connections, Element Solutions and Dover all repurchased heavily while notes payable or equity deficits rose, and Newmont's $5.2B of nine-month buybacks stood out. Several filings carry explicit event risk, including Boston Beer's $194.5M litigation charge, Element Solutions' terminated Solstice merger, and Molina's 82% nine-month profit collapse. Overall, the digest points to a market where reported profit strength is increasingly dependent on non-operating items, tax rates and leverage, so quality-of-earnings screening matters more than headline EPS.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 22, 2026

This Executive Compensation Insights digest covers 17 DEF 14A and DEFM14A filings dated October 22, 2026, and the stream is governance-focused, so most filings yield procedural rather than quantitative insight. The most material development is Personalis' merger with Tempus (materiality 9/10), where equity award treatment is disclosed but the per-share price is not in the excerpt, making the deal terms incomplete for valuation. Processa Pharmaceuticals' reverse split tied to its Vidya Therapeutics merger and $200M PIPE (materiality 8/10) carries heavy dilution, with legacy holders falling to about 1.4% of common stock. Several filings seek reverse split authority (LM Funding/PowerCompute, 20/20 Biolabs, Processa), a clear sector pattern among distressed or recapitalizing small caps. Financial distress is most visible at IGC Pharma, where operating loss widened to $7.7M from $6.0M and gross profit fell 36%, with net loss masked by non-cash other income. Compensation design themes include performance-based long-term incentives at Madison Square Garden Entertainment, and CEO performance awards and plan amendments at Copart and Aytu BioPharma. Most other filings are routine director elections and auditor ratifications with neutral sentiment.

17 high priority 17 total filings
· daily

US IPO Pipeline SEC S-1 Filings — October 22, 2026

Five SEC filings dated October 21-22, 2026 span IPO registrations (Rezera, TG-17, AlphaVest), a private-placement-style note offering (Phoenix Capital Group), and a small best-efforts follow-on (reAlpha). The most substantive quantitative picture comes from Rezera, a pre-revenue biotech whose six-month net loss widened 86% YoY to $25.5M, with R&D up ~93% and G&A up ~30%, while stockholders' deficit stands at $199.4M and actual cash at only $3.9M (pro forma $34.0M after July 2026 financings). The other filings are largely undisclosed in their enriched fields: TG-17 and AlphaVest excerpts are XBRL metadata without readable figures, so period-over-period comparisons cannot be drawn from them. Common themes are capital-raising under strain: illiquid or subordinated instruments (Phoenix), best-efforts deals with no minimum or escrow (reAlpha), and cash-burning development stage issuers (Rezera). Market implication is elevated dilution and liquidity risk across the pipeline, with the rest of the stream offering limited verifiable insight until full narrative and financial data are available.

5 high priority 5 total filings
· daily

US SEC Trading Suspension Halt Orders — October 22, 2026

The USA Trading Suspensions stream for October 22, 2026 contains three Nasdaq-related 8-K filings, all centered on listing-compliance failures rather than trading halts themselves. Atlantic American (AAME) faces the most immediate risk: it must request a Hearings Panel review by October 23, 2026 to avoid suspension after a 15-day automatic stay, following a delinquent-filing delisting determination. Alaunos Therapeutics (ALT) is mid-remediation, claiming restoration of the $2.5 million stockholders' equity requirement via a ~$350.0 million private placement and the Velaris merger, but its November 10, 2026 Panel hearing and FY2026 10-K filing will determine whether the cure holds. SenesTech (SNES) has a longer runway, receiving a minimum bid price deficiency notice with a compliance deadline of April 19, 2027. Period-over-period financial comparisons are largely absent from these filings, so quantitative trend analysis is limited; the enriched data shows no revenue, margin, insider, or capital-allocation changes for the three companies. The common theme is that delinquent reporting, sub-$1 pricing, and equity shortfalls are the triggers for Nasdaq enforcement, making monitoring of exchange notices more predictive than financial ratios in this stream.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — October 22, 2026

The 50-filing batch for the USA Executive & Director Changes stream is dominated by governance housekeeping rather than market-moving events: at least 17 filings are the same Invesco fund-sponsor PFAO handover (Kelli Gallegos leave effective Oct 19, Lori Anello appointed effective Oct 22), which is administrative and carries no fund-level impact. The substantive filings are concentrated in a handful of CFO and CEO-level transitions (Kinsale CFO succession to Tangard on March 2, 2027; Forgent Power CFO change to Amy Ard; Comfort Systems CFO retirement with Julie Shaeff as successor; Plumas Bancorp CFO transition to Kelsey Cassinelli on January 1, 2027; Frequency Electronics CFO change to Allen Kaplan on November 1, 2026; Lineage CCO retirement on April 19, 2027). Several filings carry performance or strategic content beyond the personnel change: Deckers (record Q2 sales of $1.481B, but comparable DTC down 6.4% and FY27 EPS guidance raised to $7.80-$7.95 with a ~$0.52 tariff-refund benefit), Lindsay (Q4 revenue +5% YoY but full-year revenue down 6% to $635.9M and operating income down 24%), Ategrity (Q3 net income down 35.7% YoY despite a combined ratio improvement to 84.7%), and Fractyl Health (a 45% workforce cut and Rejuva wind-down alongside positive REMAIN-1 pivotal data). The most notable leadership-driven signal is Fractyl's co-founder Jay Caplan retiring effective October 30, 2026 in the middle of a restructuring. Among CEO-level developments, the Federal Home Loan Bank of New York CEO resignation with an interim CEO appointed is the most consequential governance event, while GBank's planned succession and Evercore's co-president structure are notable for continuity planning. Because the enriched period-over-period data is sparse for most governance filings, the cross-company picture is more about the density of CFO and CAO turnover and the uniformity of the Invesco handover than about measurable financial trends.

50 high priority 50 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 22, 2026

The USA Bankruptcy & Insolvency stream for the period 2026-10-22 contains a single in-scope filing: Leslie's, Inc.'s 8-K disclosing its pre-arranged Chapter 11 filing (Southern District of Texas, Case No. 26-90795) backed by a restructuring support agreement with term loan lenders. The company and nine subsidiaries filed on September 30, 2026, and on October 20, 2026 filed a disclosure statement and joint plan of reorganization consistent with the RSA. Nasdaq delisted the common stock, which has traded on the Pink Limited Market as LESLQ since October 6, 2026, and management explicitly warns that equity holders may suffer a significant or total loss if the plan is confirmed. The filing carries maximum materiality (10/10) and negative sentiment. Because the enriched period-over-period, insider, capital allocation, and forward-looking fields are not populated for this single filing, cross-company trend analysis and quantitative comparisons are not possible; the portfolio-level read is that the dominant development is a lender-driven, pre-negotiated restructuring that prices equity as a likely wipeout. The actionable focus is on plan confirmation milestones and the treatment of existing equity under the joint plan.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 22, 2026

Across the 50 filings for the 'USA Board Room Changes' stream (all dated 2026-10-22 window), the dominant theme is a heavy concentration of officer and director transitions, with a notable cluster of identical Invesco fund-complex Item 5.02 filings in which Kelli Gallegos began a leave on October 19 and Lori Anello was appointed PFAO effective October 22; these are administrative and carry little standalone investment signal. The filings that do carry financial content show a clear divergence: Ategrity Specialty grew gross written premiums 14.7% and net earned premiums 35.7% with a record-low 84.7% combined ratio while net income fell 35.7% YoY on investment losses, Deckers posted a record $1.481B quarter (+3.5%) but with comparable DTC down 6.4% and a $0.28 tariff-refund EPS benefit masking underlying weakness, and Lindsay's full-year revenue fell 6% to $635.9M and operating income fell 24% despite a strong Q4. Fractyl Health's cost-reduction package (roughly 45% workforce cut, Rejuva wind-down, operating burn targeted to fall ~50% to about $8M per quarter) is the most material restructuring in the set. Governance-quality signals are generally benign, with most resignations explicitly stating no disagreement, though several C-suite succession events (Forgent CFO, Comfort Systems CFO, Plumas CFO, Kinsale CFO, FHLB New York CEO) concentrate finance and leadership change in the same window. Most filings lack insider-trading or capital-allocation data, so conviction read-throughs are limited.

50 high priority 50 total filings
· daily

USA Corporate Actions — October 22, 2026

This was a very quiet session for the USA Corporate Actions stream, with only one filing in the 2026-10-22 window. The lone filing is an 8-K from Allspring Global Dividend Opportunity Fund (NYSE: EOD) disclosing a fiscal year-end change from October 31 to December 31, effective with the next fiscal year, creating a two-month transition period from November 1 to December 31, 2026. The filing is administrative in nature and contains no dividend amounts, buyback activity, stock split details, rights offering terms, or performance data, so no period-over-period financial comparisons, insider transactions, or capital allocation metrics are available to analyze. Market implications are minimal; the change matters mainly for reporting cadence, since the transition period will be included in the Fund's annual report on Form N-CSR. Because the filing does not fall within the stream's core event types (Dividend, Share Buyback, Stock Split, Rights Offering), it is largely out of scope, and the digest reflects an absence of actionable corporate-action signals rather than any emerging theme.

1 medium 1 total filings
· daily

USA Insider Trading Pulse — October 22, 2026

Across the 50 Form 4 insider filings dated 2026-10-22, activity is dominated by routine compensation events (RSU/option grants, dividend equivalents, deferred-comp share credits, tax withholdings) rather than open-market conviction trades. Genuine discretionary open-market activity is limited and mixed: notable sales include State Street's Chairman/CEO (~$2.4M, 10b5-1), Intapp's President of Industries (~$1.82M, 10b5-1), Credo's CTO (~$1.29M, 10b5-1 with 14 transactions), and AAR's director (~$425K). The clearest open-market buyer is Brookfield Corp (10% owner) acquiring ~$1.28M of Brookfield Real Estate Income Trust Class I shares. The Erie Indemnity cluster (7 insiders, all at $245.94 incentive deferral credits) and the Security Midwest Bancorp board grants (7 directors, 1,334 shares plus 2,669 options each) reflect coordinated compensation cycles rather than directional views. Period-over-period comparison data was not supplied in these filings, so trend synthesis is limited to within-filing observations. Insider selling skews negative in sentiment tags, but a majority of the 50 entries are neutral compensation events, so the signal-to-noise ratio is low.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — October 22, 2026

The October 22, 2026 M&A and takeover stream is dominated by SPAC activity: of the 15 filings, roughly eight concern blank-check vehicles dealing with trust extensions, sponsor financing, Nasdaq compliance, charter amendments, IPO closings, or deal letters. Only a handful represent substantive operating-company M&A: Data I/O's ~$23 million V-TEK acquisition (expected to roughly double revenue), XCF Global's completed all-stock combination with Southern Energy and DevvStream, Janel's $17 million Encor Biotechnology sale, and NightFood's closed AOI technology acquisition. The enriched period-over-period and forward-looking fields are sparse across this set, so quantitative trend comparisons are limited; where data exists, XCF's 2027 outlook (gross product sales $650-700M, net revenue $120-130M, EBITDA $70-75M) and Data I/O's revenue-doubling claim are the most material. The clearest theme is distress and deadline pressure among small SPACs: Globa Terra faces a Nasdaq delisting with a hearing request due October 23, while ARC Group and Charlton Aria are working against warrant-value and extension deadlines. Deal-quality concerns cluster around unconfirmed targets (NightFood) and unresolved disputes at acquired operations (XCF's New Rise subsidiary). Overall tone is cautious, with positive strategic announcements tempered by financing, compliance, and execution risk.

15 high priority 15 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 22, 2026

Across 50 overnight SEC filings for October 21-22, 2026, the dominant theme is divergence between headline earnings and underlying quality. Several regional banks and insurers posted sharp year-over-year net income gains driven by lower provisions, lapped securities losses, or tax items, while sequential momentum and deposit trends softened (Eagle Bancorp, CNB Financial, First Community, Enterprise Financial, First Bancorp). Industrials and tech showed the strongest operating momentum: CSX reported record Q3 revenue of $4.02B (+12% YoY) with operating income up 44%, IBM grew revenue 5% with Software +8%, and Element Solutions posted +52% reported sales (+13% organic) though Specialties organic growth was only 1% and cash fell about 64% YTD to $224.9M after roughly $866M of acquisitions. Real estate and REITs were mixed: EastGroup delivered 7.9% FFO growth and a 12.9% dividend increase, while Crown Castle's site rental revenue fell 5% on DISH termination impacts despite an AFFO-per-share increase of 11% and a raised Adjusted EBITDA outlook. Credit stress is visible in America's Car-Mart (new $5.0M senior secured term loan amid Specified Defaults), Alaunos (Nasdaq equity compliance contingent on a $350M private placement and Velaris merger), and Genenta (sub-$1 bid, compliance period to April 14, 2027). Mortgage-sensitive names flagged a lower-for-longer origination outlook, and ARMOUR Residential posted a Q3 economic return of (12.9)%. Insider activity was modest and largely routine sales under 10b5-1 plans at MediaAlpha and ASP Isotopes, with the Southport sponsor cancelling 666,667 Class B shares.

22 high priority 28 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — October 21, 2026

This digest covers two federal construction and infrastructure awards totaling $62,231,399 in obligations, both on civilian agencies with zero defense-related contracts (0/2). The dominant theme is civilian facilities construction, with the Department of Homeland Security (FLETC) and the General Services Administration (Public Buildings Service) each funding a single NAICS 236220 commercial and institutional building project. The highest-conviction read is that both awards are fully competed, firm-fixed-price, and neutral in signal (average strength 3.0/10), so they do not establish a directional investment thesis on their own. The key watch item is the $30,613,019 GSA courthouse delivery order to ROSS GROUP CONSTRUCTION CORPORATION, LLC, which has $0 outlayed to date and subawards of $14,083,124 (about 46% of obligation), creating execution and pass-through dependency risk. Public-company status for both recipients is not established in the data, which limits materiality assessment.

2 total filings
· daily

DHS Homeland Security Contracts — October 21, 2026

Three DHS contracts totaling $90,997,880 in obligations were reviewed, all civilian with zero defense-related awards. The dominant theme is DHS civilian security and infrastructure spending: VMD Systems Integrators, LLC received a $34,998,692 TSA airport screening delivery order (Orlando Sanford, FL), Whiting-Turner Contracting Company, THE received a $31,618,380 FFP construction delivery order from FLETC for the B280 Strength & Conditioning Complex, and Deloitte Consulting LLP received a $24,380,808 SBIR/STTR award whose scope is not described in the data. Average signal strength is 3.3/10 and all three signals are rated neutral, so no contract on its own supports a strong directional thesis. The highest-conviction observation is the Whiting-Turner project, which is 86.5% outlaid ($27,363,319) against a 2027-03-30 end date, indicating active, well-advanced performance. The key watch item is the Deloitte SBIR/STTR award, whose $24,380,808 value is inconsistent with typical SBIR program sizes and whose data record is incomplete, so its significance cannot be assessed from this digest.

3 total filings
· daily

VA Healthcare & Services Contracts — October 21, 2026

Four VA healthcare and services contracts totaling $204,909,686 in obligations were awarded between June 2025 and September 2026, with zero defense-related awards, so the entire stream is civilian (Department of Veterans Affairs). The dominant theme is VA spending on IT application support and ERP sustainment, led by CACI NSS, LLC's $46,375,615 IFAMS task order and SWISH DATA CORPORATION's $86,780,922 Red Hat renewal, alongside construction and pharmacy automation work. All four signals are rated neutral (average strength 3.3/10), with materiality modest for any public parent, and no bullish or bearish directional call is warranted on this data alone. The highest-conviction observation is CACI's nine subawards totaling $54,028,703, which exceed the prime's own obligation and indicate substantial pass-through economics. The key watch item is that most headline value is contingent on option exercises (e.g., SWISH's $770,695,258 ceiling versus $86,780,922 obligated), and $0 outlays across three of four contracts means realized revenue is unconfirmed.

4 total filings
· daily

HHS & Healthcare Contracts Intelligence — October 21, 2026

This digest covers a single HHS/healthcare contract record totaling $73,196,564 in obligations, with zero defense-related awards (0 of 1), so the entire observed signal set sits on the civilian side of the federal ledger. The sole award is a delivery order from NIH/NIAID to PPD Development LP, a subsidiary of Pharmaceutical Product Development, LLC, for NIAID Clinical Site Monitoring, with $51,830,763 (about 71%) already outlayed against the obligation. The dominant theme is civilian health research services, and the signal is neutral (strength 4/10, materiality 4/10) because no public ticker or parent financials were provided to anchor a directional call. The highest-conviction observation is the large unexercised option value: the base-plus-options total of $186,449,775 is roughly 2.5x the current obligation, with a potential end date of 2031-01-31. The key watch item is whether the government exercises those options and how quickly outlays grow against the remaining obligation, since a single-contract sample cannot establish a sector trend.

1 total filings
· daily

New Federal Contractors — October 21, 2026

The 21 new federal contract awards in this period total $1,157,755,343 in obligations, with only 1 of 21 defense-related and the remainder civilian, led by Department of State, Social Security Administration, and Department of Veterans Affairs awards. The dominant theme is civilian IT and professional services spend (SSA, VA, FBI, USPTO) plus VA facility and equipment work, rather than defense modernization. The highest-materiality signal is IT Concepts, Inc.'s $107,772,236 SSA BPA call order, which is substantially funded and actively billing ($106,009,224 outlayed) with a potential end date of 2028-03-28. Investors should watch whether options are exercised before the current 2025-04-15 end date for IT Concepts and whether the many awards with $0 outlayed (including SWISH DATA, Innovation Associates, and CACI NSS) convert to recorded revenue. The period's aggregate signal is uniformly neutral (average strength 3.3/10), and most recipients are private or not identifiable as public equities from the data provided.

21 total filings
· daily

Significant Contract Modifications ($10M+) — October 21, 2026

The 21 significant contract modifications in this digest total $1,157,755,343 in obligations, with only 1 of 21 records (roughly 5%) defense-related and the remainder spread across civilian agencies including the VA, GSA, Social Security Administration, DHS, NASA, Labor and DOJ. The aggregate is dominated by civilian IT, healthcare-facility and professional-services awards rather than a defense theme, and no single contract is large enough to drive a stock-specific thesis. The highest-materiality items are the Cherokee Nation Management & Consulting $287,001,614 State Department delivery order (near-fully outlayed, non-recurring) and the IT Concepts, Inc. $107,772,236 SSA BPA call order (competed, substantially funded). Most records carry neutral signals, and the principal watch item is the cluster of option-exercise and end-date events between late 2026 and 2027, which will determine whether the headline ceilings convert to realized revenue; several recipients are privately held or nonprofit, limiting direct equity read-through.

21 total filings